BLTE - Belite Bio to Host Webcast on April 3 2023 to Discuss 2022 Full Year Financial Results
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company targeting eye diseases with significant unmet medical needs, will host a live webcast on Monday, April 3, 2023, at 4:30 p.m. Eastern time to discuss the Company’s financial results for the full year ended December 31, 2022, and provide a general business update. The financial results will be issued in a press release on Friday, March 31, 2023.
Webcast Information:
| Date: |
| Monday, April 3, 2023 |
| Time: |
| 4:30 p.m. Eastern time (1:30 a.m. Pacific time) |
| Webcast Link: |
| https://lifescievents.com/event/belite-bio-event/ |
Webcast Link Instructions
You can join the live webcast by visiting the link above or the “Presentations & Events” section of the Company’s Investor Relations website at https://investors.belitebio.com/presentations-events/events . A replay will be available approximately two hours after the event for 90 days.
About Belite Bio
Belite Bio is a San Diego based clinical stage biopharmaceutical drug development company targeting eye diseases with significant unmet medical needs, such as advanced age-related macular degeneration (commonly known as Geographic Atrophy or advanced Dry AMD) and Stargardt disease, and metabolic diseases. For more information, follow us on Twitter , Instagram , LinkedIn , Facebook or visit us at www.belitebio.com .
Media and Investor Relations Contact:
Jennifer Wu / ir@belitebio.com
Tim McCarthy /tim@lifesciadvisors.com